| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |